Please Scroll Down to See Forums Below 
geoboy
New member
this will go well with the new synthetic HDL, soon I'll be able to eat the deep-fried sugar coated lard-balls without dying AND without losing the 6-pack. its a good time to be alive 
.
from ANANOVA
Scientists on way to developing obesity pill
British researchers are trying to develop a pill which could be used to treat obesity without the slimmer having to cut down on what they eat.
The team at Aston University in Birmingham are looking at the role of a protein, called zinc alpha 2 glycoprotein (ZAG), which appears to promote weight loss without an obese person having to reduce their food intake.
This happens because the protein targets fat breakdown while not affecting muscle mass.
Professor Mike Tisdale said their long-term plan was to try to turn ZAG into a treatment, such as a tablet, to treat obesity.
ZAG, a soluble protein, is present in most body fluids and in most normal tissues of the body.
But the protein is also involved in a process called cachexia - the weight loss that happens in some cancer patients.
During cachexia, ZAG production is increased 10-fold, causing the movement of fat from adipose tissue which is used to produce heat rather than energy.
This can lead to cancer patients losing 85% of their body fat.
This fat mobilisation is normally linked to energy demand, so anything which disrupts this process will lead to progressive fat loss.
The process has been extensively examined by Prof Tisdale, leading him to use the protein to target obesity.
Story filed: 18:09 Thursday 6th November 2003
.from ANANOVA
Scientists on way to developing obesity pill
British researchers are trying to develop a pill which could be used to treat obesity without the slimmer having to cut down on what they eat.
The team at Aston University in Birmingham are looking at the role of a protein, called zinc alpha 2 glycoprotein (ZAG), which appears to promote weight loss without an obese person having to reduce their food intake.
This happens because the protein targets fat breakdown while not affecting muscle mass.
Professor Mike Tisdale said their long-term plan was to try to turn ZAG into a treatment, such as a tablet, to treat obesity.
ZAG, a soluble protein, is present in most body fluids and in most normal tissues of the body.
But the protein is also involved in a process called cachexia - the weight loss that happens in some cancer patients.
During cachexia, ZAG production is increased 10-fold, causing the movement of fat from adipose tissue which is used to produce heat rather than energy.
This can lead to cancer patients losing 85% of their body fat.
This fat mobilisation is normally linked to energy demand, so anything which disrupts this process will lead to progressive fat loss.
The process has been extensively examined by Prof Tisdale, leading him to use the protein to target obesity.
Story filed: 18:09 Thursday 6th November 2003
